These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3451885)

  • 1. Effects of bradycardic agents on ischaemic myocardium and perfusion in anesthetized dogs.
    Gross GJ; Daemmgen JW
    Eur Heart J; 1987 Dec; 8 Suppl L():69-74. PubMed ID: 3451885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs.
    Gross GJ; Daemmgen JW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):422-8. PubMed ID: 3735124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the new specific bradycardia agent AQ-A39 (falipamil) on coronary collateral blood flow in dogs.
    Gross GJ; Daemmgen JW
    J Cardiovasc Pharmacol; 1987 Jul; 10(1):123-7. PubMed ID: 2441148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of AQ-AH 208, a new specific bradycardic agent, on myocardial ischemia-reperfusion injury in anesthetized dogs.
    Gross GJ; Warltier DC; Daemmgen JW
    J Cardiovasc Pharmacol; 1985; 7(5):929-36. PubMed ID: 2413303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AQ-AH 208, a new bradycardic agent, increases coronary collateral blood flow to ischemic myocardium.
    Daemmgen JW; Gross GJ
    J Cardiovasc Pharmacol; 1985; 7(6):1048-54. PubMed ID: 2418287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function.
    Dämmgen JW; Lamping KA; Gross GJ
    J Cardiovasc Pharmacol; 1985; 7(1):71-9. PubMed ID: 2580154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of AQ-A 39 with propanolol and placebo in ischaemic heart disease.
    Gilfrich HJ; Oberhoffer M; Witzke J
    Eur Heart J; 1987 Dec; 8 Suppl L():147-51. PubMed ID: 3330526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of three bradycardiac drugs on regional myocardial blood flow and function in areas distal to a total or partial coronary occlusion in dogs.
    Gross GJ; Lamping KG; Warltier DC; Hardman HF
    Circulation; 1984 Feb; 69(2):391-9. PubMed ID: 6690105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of AQ-A39, a bradycardic agent, on cardiovascular responses to isoproterenol in the anesthetized dog.
    Wenger HC; Siegl PK
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):246-53. PubMed ID: 2436007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia.
    Guth BD; Heusch G; Seitelberger R; Matsuzaki M; Ross J
    Eur Heart J; 1987 Dec; 8 Suppl L():61-8. PubMed ID: 3451884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in functional recovery of stunned canine myocardium by long-term pretreatment with oral propranolol.
    al-Wathiqui MH; Farber N; Pelc L; Gross GJ; Brooks HL; Warltier DC
    Am Heart J; 1989 Apr; 117(4):791-8. PubMed ID: 2929396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a specific bradycardic agent (AQ-A39) and verapamil on beta-adrenergic responses in isolated guinea pig atria.
    Siegl PK; Morgan G
    Can J Physiol Pharmacol; 1987 Feb; 65(2):146-51. PubMed ID: 3032382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esmolol decreases the adverse effects of acute coronary artery occlusion on myocardial metabolism and regional myocardial blood flow in dogs.
    Sidi A; Davis RF
    Anesth Analg; 1988 Feb; 67(2):124-30. PubMed ID: 2829657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
    Kobinger W; Lillie C
    Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow.
    Gross GJ; Warltier DC; Hardman HF
    J Cardiovasc Pharmacol; 1984; 6(1):61-7. PubMed ID: 6199613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
    Wouters PF; Marcus MA; Van Aken HK; van de Velde M; Miserez M; Deruyter HA; Mignolet K; Flameng W
    Eur J Anaesthesiol; 1994 Sep; 11(5):381-90. PubMed ID: 7988582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of coronary blood flow during acute coronary occlusion in dogs. Effect of nicotinic acid and sodium salicylate.
    Vik-Mo H
    Scand J Clin Lab Invest; 1977 Dec; 37(8):697-703. PubMed ID: 601512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
    Jolly SR; Hardman HF; Gross GJ
    J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.